User profiles for Christina M. Lockwood
Christina M LockwoodAssociate Professor of Laboratory Medicine, University of Washington Verified email at uw.edu Cited by 4396 |
Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review
…, N Lindeman, CM Lockwood… - … of pathology & …, 2018 - meridian.allenpress.com
Purpose.— Clinical use of analytical tests to assess genomic variants in circulating tumor
DNA (ctDNA) is increasing. This joint review from the American Society of Clinical Oncology …
DNA (ctDNA) is increasing. This joint review from the American Society of Clinical Oncology …
Comparison of symptoms and RNA levels in children and adults with SARS-CoV-2 infection in the community setting
…, B Pfau, A Adler, K Lacombe, CM Lockwood… - JAMA …, 2021 - jamanetwork.com
Importance The association between COVID-19 symptoms and SARS-CoV-2 viral levels in
children living in the community is not well understood. Objective To characterize symptoms …
children living in the community is not well understood. Objective To characterize symptoms …
Clinical next‐generation sequencing in patients with non–small cell lung cancer
IS Hagemann, S Devarakonda, CM Lockwood… - Cancer, 2015 - Wiley Online Library
BACKGROUND A clinical assay was implemented to perform next‐generation sequencing (NGS)
of genes commonly mutated in multiple cancer types. This report describes the …
of genes commonly mutated in multiple cancer types. This report describes the …
[HTML][HTML] Validation of a next-generation sequencing assay for clinical molecular oncology
…, DH Spencer, HJ Abel, CM Lockwood… - The Journal of molecular …, 2014 - Elsevier
Currently, oncology testing includes molecular studies and cytogenetic analysis to detect
genetic aberrations of clinical significance. Next-generation sequencing (NGS) allows rapid …
genetic aberrations of clinical significance. Next-generation sequencing (NGS) allows rapid …
Pan-Trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors
ER Rudzinski, CM Lockwood, BA Stohr… - The American journal …, 2018 - journals.lww.com
Activating neurotrophic receptor kinase (NTRK) fusions define certain pediatric mesenchymal
tumors, including infantile fibrosarcoma and cellular mesoblastic nephroma. Traditionally, …
tumors, including infantile fibrosarcoma and cellular mesoblastic nephroma. Traditionally, …
[HTML][HTML] Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data
A recurrent somatic mutation frequently found in cytogenetically normal acute myeloid
leukemia (AML) is internal tandem duplication (ITD) in the fms-related tyrosine kinase 3 gene (…
leukemia (AML) is internal tandem duplication (ITD) in the fms-related tyrosine kinase 3 gene (…
Early detection of Covid-19 through a citywide pandemic surveillance platform
…, B Martin, CM Lockwood, M Thompson… - … England Journal of …, 2020 - Mass Medical Soc
Detection of Covid-19 through a Citywide Surveillance Platform The Seattle Flu study, initiated
in 2018, mailed kits for home collection of midnasal swabs to people reporting respiratory …
in 2018, mailed kits for home collection of midnasal swabs to people reporting respiratory …
Expanding the spectrum of pediatric NTRK-rearranged mesenchymal tumors
JL Davis, CM Lockwood, B Stohr… - The American journal …, 2019 - journals.lww.com
Pediatric mesenchymal tumors harboring variant NTRK fusions (ETV6-negative) are being
increasingly described; however, the histologic and clinical features of these variant NTRK …
increasingly described; however, the histologic and clinical features of these variant NTRK …
Infantile NTRK-associated Mesenchymal Tumors
JL Davis, CM Lockwood, CM Albert… - Pediatric and …, 2018 - journals.sagepub.com
Pediatric fibroblastic/myofibroblastic lesions are a relatively common group of tumors with
varying morphologies, for which the molecular mechanisms are becoming increasingly well …
varying morphologies, for which the molecular mechanisms are becoming increasingly well …
Microsatellite instability in prostate cancer by PCR or next-generation sequencing
JA Hempelmann, CM Lockwood, EQ Konnick… - … for immunotherapy of …, 2018 - Springer
Background Microsatellite instability (MSI) is now being used as a sole biomarker to guide
immunotherapy treatment for men with advanced prostate cancer. Yet current molecular …
immunotherapy treatment for men with advanced prostate cancer. Yet current molecular …